Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated adding rituximab to combination chemotherapy in patients with previously treated chronic lymphocytic leukemia; the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Rituximab (Rituxan) (rituximab)

Snippet

Sponsor: Cancer Research UK | Conditions: Leukemia | Phase 2 | Status: COMPLETED